Biochemical Pathophysiology & MNT Objectives
Type 2 Diabetes Mellitus (T2DM) is characterized by progressive peripheral insulin receptor desensitization, hepatic insulin resistance leading to uninhibited gluconeogenesis, and secondary beta-cell secretory exhaustion. Chronic postprandial hyperglycemia accelerates the formation of Advanced Glycation End-products (AGEs), triggering vascular endothelial dysfunction, microvascular damage (nephropathy, retinopathy, neuropathy), and macrovascular atherosclerotic risk.
Syntro Health's Medical Nutrition Therapy (MNT) targets metabolic homeostasis through cellular macronutrient partitioning. Rather than simple carbohydrate restriction, our algorithm emphasizes the glycemic index (GI) and glycemic load (GL) of regional Indian food matrices, essential amino acid (EAA) pacing to stimulate glucagon-like peptide-1 (GLP-1), and therapeutic micronutrient cofactors (chromium, magnesium, zinc) that augment insulin signaling cascades.
Daily Macronutrient & Micronutrient Targets
Calibrated against ICMR-NIN 2020 RDA tables and international condition consensus standards:
| Nutrient | Clinical Target | Physiological Rationale |
|---|---|---|
| Carbohydrates | 45–50% total energy | Exclusively low-GI (<55), unrefined complex carbohydrates with intact bran layers. |
| Dietary Fiber | 35–45 g/day (≥15g soluble) | Viscous soluble fibers (beta-glucan, psyllium, fenugreek galactomannan) to delay gastric emptying. |
| Protein | 1.0–1.2 g/kg body weight | Prioritizing legumes, lentils, low-fat paneer, tofu, and egg whites; timed to induce satiety. |
| Fat Distribution | 25–30% total energy | SFA <7%, MUFA 15–20% (mustard/olive oil), PUFA n-6:n-3 ratio calibrated between 3:1 and 5:1. |
| Glycemic Load Floor | <80 GL/day | Single meal load restricted to ≤20 GL to prevent acute insulin demand. |
Therapeutic Food Matrix: Foods to Prioritize vs. Avoid
Foods to Include
Contains 4-hydroxyisoleucine which stimulates glucose-dependent insulin secretion and inhibits alpha-glucosidase.
Rich in slowly digestible starch and resistant starch; low glycemic index (GI ~28) blunts postprandial glucose spikes.
Contains charantin, vicine, and polypeptide-p which mimic insulin activity and enhance peripheral glucose uptake.
Abundant beta-glucan forms viscous mucosal hydrogel, slowing intestinal carbohydrate absorption and stabilizing HbA1c.
Exceptional natural ascorbate and ellagitannin profile, protecting pancreatic islet beta cells from oxidative apoptosis.
Foods to Restrict
De-husked refined starch with GI >75 that causes acute postprandial hyperglycemia and hyperinsulinemia.
Rapidly hydrolyzed amylopectin devoid of dietary fiber; elevates triglycerides and inflammatory cytokines.
Equal glycemic consequence to table sucrose; accelerates hepatic de novo lipogenesis and dyslipidemia.
Oxidized lipids induce mitochondrial stress, endoplasmic reticulum stress, and impair insulin-stimulated GLUT4 translocation.
Bypasses hepatic phosphofructokinase regulation, driving visceral adiposity and hepatic steatosis.
Pharmacological & Drug-Nutrient Safeguards
Syntro Health checks 30+ deterministic pharmacology rules before delivering your meal plan:
Inhibits ileal calcium-dependent uptake of B12. Syntro automatically flags dietary B12 monitoring and supplementation.
Requires strict carb distribution across 3 primary meals and 2 snacks; forbids unplanned prolonged fasting.
Mandates baseline fluid intake ≥2.5–3.0 L/day and maintains absolute carb floor of ≥130g/day.
How Syntro Health Builds Your Type 2 Diabetes Mellitus Protocol
Clinical Biomarker Ingestion
The system imports your latest fasting glucose, postprandial sugar, and HbA1c metrics alongside lipid profile values.
Mifflin-St Jeor Energy Calibration
Computes exact Basal Energy Expenditure (BEE) with Adjusted Body Weight (ABW) correction if BMI ≥ 27.5 kg/m².
Glycemic Load & Carbohydrate Partitioning
Sets individual meal glycemic load caps (≤20 GL per meal, ≤80 GL daily) across unrefined, high-fiber Indian carbohydrates.
Pharmacological Safety Cross-Check
Validates food matrix safety against Metformin, Sulfonylureas, or DPP-4 inhibitors to prevent hypoglycemic episodes.
7-Day Dual-Protocol Meal Assembly
Generates day-by-day recipes with gram-exact portion sizes, preparation instructions, and essential amino acid profiles.
Frequently Asked Questions
Clinical Evidence & Guidelines Referenced
- American Diabetes Association: Standards of Medical Care in Diabetes—2026 — ElSayed NA, et al.. Diabetes Care 2026;49(Suppl 1):S1-S270. Source link
- ICMR-NIN Nutrient Requirements for Indians & Recommended Dietary Allowances — National Institute of Nutrition (ICMR). Hyderabad: ICMR-NIN, 2020. Source link
- Indian Food Composition Tables (IFCT 2017) — Longvah T, Ananthan R, Bhaskarachary K, Venkaiah K. National Institute of Nutrition, 2017. Source link